Commission proposes to purchase up to 300 million additional doses of BioNTech-Pfizer vaccine

Brussels, 08/01/2021 - 15:44, UNIQUE ID: 210111_4

Press releases

The European Commission today proposed to the EU Member States to purchase an additional 200 million doses of the COVID-19 vaccine produced by BioNTech and Pfizer, with the option to acquire another 100 million doses.

Tags:

Coronavirus

Author

EEAS Press Team

Contact the Press Team of the European External Action Service

You might be interested in

Coronavirus: Commission approves contract with BioNTech-Pfizer alliance to ensure access to a potential vaccineEU News 314/2020
Coronavirus: Commission approves second contract with Moderna to ensure up to additional 300 million dosesToday, the European Commission approved a second contract with the pharmaceutical company Moderna, which provides for an additional purchase of 300 million doses (150 million in 2021 and an option to purchase an additional 150 million in 2022) on behalf of all EU Member States. The new contract also
Coronavirus: Commission approves second contract with Moderna to ensure up to additional 300 million doses press Category: Press releases Regions: Asia Pakistan Editorial Sections: Pakistan Unique ID: 210218_12 Press Location: Brussels
EU-supported COVAX/ GAVI facility approves delivery of BioNTech- Pfizer and AstraZeneca / SKBio COVID-19 vaccines to the Republic of Moldova The European Union welcomes the decision of the EU-supported COVAX/GAVI facility of 29 January 2021 to allocate 24,570 doses of BioNTech- Pfizer COVID-19 vaccine and up to 264,000 indicative doses of AstraZeneca / SKBio COVID-19 vaccine to the Republic of Moldova. With EUR 853 million, the EU is

Quick Network Access

Loading EEAS categories...

Sign-up

Commission proposes to purchase up to 300 million additional doses of BioNTech-Pfizer vaccine

Sign-up